The Freestyle Libre 14 day is now the longest-lasting self-applied continuous glucose sensing technology available and allows the used to wear the sensor for up to 14 days with high accuracy.

The FreeStyle Libre 3 system is the most accurate 14-day continuous glucose monitor1, with readings sent directly to a smartphone every minute.2 Designed for access and affordability, the ...

A new study published in US Endocrinology found Abbott’s continuous glucose monitoring system, the FreeStyle Libre, demonstrated significant cost savings for diabetic care compared to traditional ...

(RTTNews) - Abbott (ABT) said late-breaking clinical data showed the FreeStyle Libre 3 system has an overall mean absolute relative difference (MARD) of 7.9%, making it the first and only 14-day ...

The FDA cleared the FreeStyle Libre 3 system, Abbott said Tuesday, and the company will begin rolling out the glucose sensor to participating pharmacies later this year.

* ABBOTT'S FREESTYLE® LIBRE 14 DAY SYSTEM NOW AVAILABLE IN U.S. FOR HOSPITALIZED PATIENTS WITH DIABETES * ABBOTT - WILL DONATE 25,000 FREESTYLE LIBRE 14 DAY SENSORS Source text for Eikon: Further ...

The next-generation FreeStyle Libre 3 sensor, worn on the back of the upper arm for 14 days, is 70% thinner than the Libre 2.

Tandem Diabetes Care's t:slim X2 insulin pump becomes the first to integrate with Abbott's FreeStyle Libre 2 Plus Sensor for US users.

Abbott Laboratories Inc. announced U.S. FDA clearance for its next-generation Freestyle Libre 3 continuous glucose monitor (CGM) system for people aged 4 years and older with diabetes. Accuracy of the ...